<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35463767</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>The Additive Value of Cardiovascular Magnetic Resonance in Convalescent COVID-19 Patients.</ArticleTitle><Pagination><StartPage>854750</StartPage><MedlinePgn>854750</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">854750</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2022.854750</ELocationID><Abstract><AbstractText>In COVID-19 the development of severe viral pneumonia that is coupled with systemic inflammatory response triggers multi-organ failure and is of major concern. Cardiac involvement occurs in nearly 60% of patients with pre-existing cardiovascular conditions and heralds worse clinical outcome. Diagnoses carried out in the acute phase of COVID-19 rely upon increased levels of circulating cardiac injury biomarkers and transthoracic echocardiography. These diagnostics, however, were unable to pinpoint the mechanisms of cardiac injury in COVID-19 patients. Identifying the main features of cardiac injury remains an urgent yet unmet need in cardiology, given the potential clinical consequences. Cardiovascular magnetic resonance (CMR) provides an unparalleled opportunity to gain a deeper insight into myocardial injury given its unique ability to interrogate the properties of myocardial tissue. This endeavor is particularly important in convalescent COVID-19 patients as many continue to experience chest pain, palpitations, dyspnea and exertional fatigue, six or more months after the acute illness. This review will provide a critical appraisal of research on cardiovascular damage in convalescent adult COVID-19 patients with an emphasis on the use of CMR and its value to our understanding of organ damage.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Borlotti, Thomaides-Brears, Georgiopoulos, Banerjee, Robson, Fusco and Masci.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borlotti</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perspectum Ltd., Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomaides-Brears</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Perspectum Ltd., Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgiopoulos</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Rajarshi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Perspectum Ltd., Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robson</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Perspectum Ltd., Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fusco</LastName><ForeName>Dahlene N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masci</LastName><ForeName>Pier-Giorgio</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Perspectum Ltd., Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiovascular magnetic resonanace</Keyword><Keyword MajorTopicYN="N">convalescent COVID-19 patients</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">multi-organ damage</Keyword><Keyword MajorTopicYN="N">myocardial injury</Keyword></KeywordList><CoiStatement>AB, HT-B, MR, RB, and PG-M are employees of Perspectum Ltd., a privately-funded commercial enterprise that develops medical devices to address unmet clinical needs, including CoverScan&#x2122;. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>25</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35463767</ArticleId><ArticleId IdType="pmc">PMC9021393</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.854750</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization.
Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease is Suspected: Interim Guidance, 13 March.
Institutional Repository for Information Sharing;  (2020). Available online at: https://apps.who.int/iris/handle/10665/331446
(accessed November 16, 2021).</Citation></Reference><Reference><Citation>Hippisley-Cox J, Coupland CA, Mehta N, Keogh RH, Diaz-Ordaz K, Khunti K, et al. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study. BMJ. (2021) 374:n2244. 10.1136/bmj.n2244</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2244</ArticleId><ArticleId IdType="pmc">PMC8446717</ArticleId><ArticleId IdType="pubmed">34535466</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics.
Coronavirus (COVID-19) Latest Insights. (2022). Available online at: https://www.ons.gov.uk/peoplepopulationand community/healthandsocialcare/conditionsanddiseases/articles/coronavirus covid19latestinsights/overview
(accessed January 13, 2022).</Citation></Reference><Reference><Citation>Ferguson N, Ghani AC, Cori A, Hogan A, Hinsley W, Volz E. Report 49 &#x2013; Growth, Population Distribution and Immune Escape of Omicron in England. London: Imperial College; (2021).</Citation></Reference><Reference><Citation>Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID&#x2013;19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. (2020) 17:543&#x2013;58. 10.1038/s41569-020-0413-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. (2020) 5:802&#x2013;10. 10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:811&#x2013;8. 10.1001/jamacardio.2020.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison SL, Buckley BJR, Rivera-Caravaca JM, Zhang J, Lip GYH. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Heart J Qual Care Clin Outcomes. (2021) 7:330&#x2013;9. 10.1093/ehjqcco/qcab029</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcab029</ArticleId><ArticleId IdType="pmc">PMC8294691</ArticleId><ArticleId IdType="pubmed">34107535</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Han Y, Jaffr&#xe9; F, Nilsson-Payant BE, Bram Y, Wang P, et al. An immuno-cardiac model for macrophage-mediated inflammation in COVID-19 hearts. Circ Res. (2021) 129:33&#x2013;46. 10.1161/CIRCRESAHA.121.319060</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319060</ArticleId><ArticleId IdType="pmc">PMC8225586</ArticleId><ArticleId IdType="pubmed">33853355</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ. (2020) 370:m3489. 10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. Geneva: World Health Organization; (2021).</Citation></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. (2021) 4:e2128568. 10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics.
Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK: 4 November 2021. (2021). Available online at: https://www.ons.gov.uk/peoplepopulationand community/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceof ongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/4november 2021#prevalence-of-ongoing-symptoms-following-coronavirus-infection-in-the-uk-data
(accessed November 15, 2021).</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, Marks M, Livingston R, Ridsdale HA, et al. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir Res. (2021) 8:e001041. 10.1136/bmjresp-2021-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. (2021) 4:e210830. 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>FAIR Health. A Detailed Study of Patients with Long-Haul COVID: An Analysis of Private Healthcare Claims. A FAIR Health White Paper. (2021). Available online at: https://s3.amazonaws.com/media2.fairhealth.org/whitepaper/asset/A%20Detailed%20Study%20of%20Patients%20with%20Long-Haul%20COVID&#x2013;An%20Analysis%20of%20Private%20Healthcare%20Claims&#x2013;A%20FAIR%20Health%20White%20Paper.pdf
(accessed December 16, 2021).</Citation></Reference><Reference><Citation>Bisaccia G, Ricci F, Recce V, Serio A, Iannetti G, Chahal AA, et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J Cardiovasc Dev Dis. (2021) 8:156. 10.3390/jcdd8110156</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd8110156</ArticleId><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. (2021) 398:747&#x2013;58. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Chen S, Pasea L, Lai AG, Katsoulis M, Denaxas S, et al. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol. (2021) 28:1599&#x2013;609. 10.1093/eurjpc/zwaa155</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwaa155</ArticleId><ArticleId IdType="pmc">PMC7928969</ArticleId><ArticleId IdType="pubmed">33611594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball S, Banerjee A, Berry C, Boyle JR, Bray B, Bradlow W, et al. Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK. Heart. (2020) 106:1890&#x2013;7. 10.1136/heartjnl-2020-317870</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317870</ArticleId><ArticleId IdType="pmc">PMC7536637</ArticleId><ArticleId IdType="pubmed">33020224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. (2021) 372:n693. 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054&#x2013;62. 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. (2020) 395:497&#x2013;506. 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. (2020) 382:1708&#x2013;20. 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. (2020) 26:1017&#x2013;32. 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol. (2021) 1&#x2013;10. 10.1038/s41569-021-00631-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00631-3</ArticleId><ArticleId IdType="pmc">PMC8532434</ArticleId><ArticleId IdType="pubmed">34686843</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B, Asatryan B, Hanff TC, Chatha SR, Khanji MY, Ricci F, et al. The pathogenesis and long-term consequences of COVID-19 cardiac injury. JACC Basic Transl Sci. (2022). 10.1016/j.jacbts.2021.10.011 [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.10.011</ArticleId><ArticleId IdType="pmc">PMC8828362</ArticleId><ArticleId IdType="pubmed">35165665</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Fitzek A, Br&#xe4;uninger H, Aleshcheva G, Edler C, Meissner K, et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. (2020) 5:1281&#x2013;5. 10.1001/jamacardio.2020.3551</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3551</ArticleId><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. (2021) 50:107300. 10.1016/j.carpath.2020.107300</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107300</ArticleId><ArticleId IdType="pmc">PMC7583586</ArticleId><ArticleId IdType="pubmed">33132119</ArticleId></ArticleIdList></Reference><Reference><Citation>Bois MC, Boire NA, Layman AJ, Aubry M-C, Alexander MP, Roden AC, et al. COVID-19&#x2013;associated nonocclusive fibrin microthrombi in the heart. Circulation. (2021) 143:230&#x2013;43. 10.1161/CIRCULATIONAHA.120.050754</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050754</ArticleId><ArticleId IdType="pmc">PMC7805556</ArticleId><ArticleId IdType="pubmed">33197204</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Leone O, Rizzo S, De Gaspari M, van der Wal AC, Aubry M-C, et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J. (2020) 41:3827&#x2013;35. 10.1093/eurheartj/ehaa664</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa664</ArticleId><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi M, et al. Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol. (2020) 76:2043&#x2013;55. 10.1016/j.jacc.2020.08.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.069</ArticleId><ArticleId IdType="pmc">PMC7588179</ArticleId><ArticleId IdType="pubmed">33121710</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging. (2020) 21:949&#x2013;58. 10.1093/ehjci/jeaa178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa178</ArticleId><ArticleId IdType="pmc">PMC7337658</ArticleId><ArticleId IdType="pubmed">32556199</ArticleId></ArticleIdList></Reference><Reference><Citation>Corica B, Marra AM, Basili S, Cangemi R, Cittadini A, Proietti M, et al. Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis. Sci Rep. (2021) 11:17774. 10.1038/s41598-021-96955-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96955-8</ArticleId><ArticleId IdType="pmc">PMC8423751</ArticleId><ArticleId IdType="pubmed">34493763</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody WE, Mahmoud-Elsayed HM, Senior J, Gul U, Khan-Kheil AM, Horne S, et al. Impact of right ventricular dysfunction on mortality in patients hospitalized with COVID-19, according to race. CJC Open. (2021) 3:91. 10.1016/j.cjco.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7502228</ArticleId><ArticleId IdType="pubmed">32984798</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. (2009) 53:1475&#x2013;87. 10.1016/j.jacc.2009.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.02.007</ArticleId><ArticleId IdType="pmc">PMC2743893</ArticleId><ArticleId IdType="pubmed">19389557</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. (2018) 72:3158&#x2013;76. 10.1016/j.jacc.2018.09.072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.09.072</ArticleId><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Lurz P, Luecke C, Eitel I, F&#xf6;hrenbach F, Frank C, Grothoff M, et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the myoracer-trial. J Am Coll Cardiol. (2016) 67:1800&#x2013;11. 10.1016/j.jacc.2016.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.02.013</ArticleId><ArticleId IdType="pubmed">27081020</ArticleId></ArticleIdList></Reference><Reference><Citation>Everett RJ, Treibel TA, Fukui M, Lee H, Rigolli M, Singh A, et al. Extracellular myocardial volume in patients with aortic stenosis. J Am Coll Cardiol. (2020) 75:304&#x2013;16. 10.1016/j.jacc.2019.11.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.11.032</ArticleId><ArticleId IdType="pmc">PMC6985897</ArticleId><ArticleId IdType="pubmed">31976869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Han K, Suh YJ. Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J Cardiovasc Magn Reson. (2021) 23:100. 10.1186/s12968-021-00792-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00792-7</ArticleId><ArticleId IdType="pmc">PMC8414035</ArticleId><ArticleId IdType="pubmed">34479603</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight DS, Kotecha T, Razvi Y, Chacko L, Brown JT, Jeetley PS, et al. COVID-19 myocardial injury in survivors. Circulation. (2020) 142:1120&#x2013;2. 10.1161/CIRCULATIONAHA.120.049252</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049252</ArticleId><ArticleId IdType="pmc">PMC7492396</ArticleId><ArticleId IdType="pubmed">32673505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T, Knight DS, Razvi Y, Kumar K, Vimalesvaran K, Thornton G, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. (2021) 42:1866&#x2013;78. 10.1093/eurheartj/ehab075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. (2021) 31:100683. 10.1016/j.eclinm.2020.100683</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar MP, Tunnicliffe EM, Petousi N, Lewandowski AJ, Xie C, Mahmod M, et al. Symptom persistence despite improvement in cardiopulmonary health &#x2013; insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine. (2021) 41:101159. 10.1016/j.eclinm.2021.101159</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101159</ArticleId><ArticleId IdType="pmc">PMC8527025</ArticleId><ArticleId IdType="pubmed">34693230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Deng K-Q, Li C, Yang Z, Hu H, Cai H, et al. Cardiac involvement in recovered patients from COVID-19: a preliminary 6-month follow-up study. Front Cardiovasc Med. (2021) 8:654405. 10.3389/fcvm.2021.654405</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.654405</ArticleId><ArticleId IdType="pmc">PMC8155269</ArticleId><ArticleId IdType="pubmed">34055936</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wang H, Zhao R, Wang T, Zhu Y, Qian Y, et al. Elevated extracellular volume fraction and reduced global longitudinal strains in participants recovered from COVID-19 without clinical cardiac findings. Radiology. (2021) 299:E230&#x2013;40. 10.1148/radiol.2021203998</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203998</ArticleId><ArticleId IdType="pmc">PMC7808090</ArticleId><ArticleId IdType="pubmed">33434112</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:1265&#x2013;73. 10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel E, Puntmann VO. Errors in statistical numbers and data in study of cardiovascular magnetic resonance imaging in patients recently recovered from COVID-19. JAMA Cardiol. (2020) 5:1307&#x2013;8. 10.1001/jamacardio.2020.4661</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.4661</ArticleId><ArticleId IdType="pubmed">32840561</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancy CW, Fonarow GC. Coronavirus disease 2019 (COVID-19) and the heart&#x2014;is heart failure the next chapter? JAMA Cardiol. (2020) 5:1216&#x2013;7. 10.1001/jamacardio.2020.3575</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3575</ArticleId><ArticleId IdType="pubmed">32730614</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippetti L, Pace N, Marie P-Y. Cardiac involvement after recovering from COVID-19. JAMA Cardiol. (2021) 6:243&#x2013;4. 10.1001/jamacardio.2020.5279</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.5279</ArticleId><ArticleId IdType="pubmed">33112937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. (2020) 13:2330&#x2013;9. 10.1016/j.jcmg.2020.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy G, Artico J, Kurdi H, Seraphim A, Lau C, Thornton GD, et al. Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. JACC Cardiovasc Imaging. (2021) 14:2155&#x2013;66. 10.1016/j.jcmg.2021.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.04.011</ArticleId><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. (2021) 11:e048391&#x2013;048391. 10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Starekova J, Bluemke DA, Bradham WS, Eckhardt LL, Grist TM, Kusmirek JE, et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. (2021) 6:945&#x2013;50. 10.1001/jamacardio.2020.7444</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.7444</ArticleId><ArticleId IdType="pmc">PMC7809616</ArticleId><ArticleId IdType="pubmed">33443537</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DE, Parikh A, Dendy JM, Diamond AB, George-Durrett K, Fish FA, et al. COVID-19 myocardial pathology evaluation in athletes with cardiac magnetic resonance (COMPETE CMR). Circulation. (2021) 143:609&#x2013;12. 10.1161/CIRCULATIONAHA.120.052573</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052573</ArticleId><ArticleId IdType="pmc">PMC7864610</ArticleId><ArticleId IdType="pubmed">33332151</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from covid-19 infection. JAMA Cardiol. (2021) 6:116&#x2013;8. 10.1001/jamacardio.2020.4916</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.4916</ArticleId><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Vago H, Szabo L, Dohy Z, Merkely B. Cardiac magnetic resonance findings in patients recovered from COVID-19. JACC Cardiovasc Imaging. (2021) 14:1279&#x2013;81. 10.1016/j.jcmg.2020.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.11.014</ArticleId><ArticleId IdType="pmc">PMC7837171</ArticleId><ArticleId IdType="pubmed">33341416</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels CJ, Rajpal S, Greenshields JT, Rosenthal GL, Chung EH, Terrin M, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent sars-cov-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. (2021) 6:1078&#x2013;87. 10.1001/jamacardio.2021.2065</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2065</ArticleId><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito D, Meester S, Yanamala N, Patel HB, Balcik BJ, Casaclang-Verzosa G, et al. High prevalence of pericardial involvement in college student athletes recovering from COVID-19. JACC Cardiovasc Imaging. (2021) 14:541&#x2013;55. 10.1016/j.jcmg.2020.10.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.10.023</ArticleId><ArticleId IdType="pmc">PMC7641597</ArticleId><ArticleId IdType="pubmed">33223496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x142;ek &#x141;A, Marczak M, Mi&#x142;osz-Wieczorek B, Konopka M, Braksator W, Drygas W, et al. Cardiac involvement in consecutive elite athletes recovered from Covid-19: a magnetic resonance study. J Magn Reson Imaging. (2021) 53:1723&#x2013;9. 10.1002/jmri.27513</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27513</ArticleId><ArticleId IdType="pmc">PMC8014772</ArticleId><ArticleId IdType="pubmed">33474768</ArticleId></ArticleIdList></Reference><Reference><Citation>Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, et al. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med. (2021) 385:2132&#x2013;9. 10.1056/NEJMoa2110737</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110737</ArticleId><ArticleId IdType="pmc">PMC8531986</ArticleId><ArticleId IdType="pubmed">34614329</ArticleId></ArticleIdList></Reference><Reference><Citation>Mevorach D, Anis E, Cedar N, Bromberg M, Haas EJ, Nadir E, et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N Engl J Med. (2021) 385:2140&#x2013;9. 10.1056/NEJMoa2109730</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109730</ArticleId><ArticleId IdType="pmc">PMC8531987</ArticleId><ArticleId IdType="pubmed">34614328</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. (2021) 6:1202&#x2013;6. 10.1001/jamacardio.2021.2833</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2833</ArticleId><ArticleId IdType="pmc">PMC8243257</ArticleId><ArticleId IdType="pubmed">34185045</ArticleId></ArticleIdList></Reference><Reference><Citation>Switzer C, Loeb M. Evaluating the relationship between myocarditis and mRNA vaccination. Expert Rev Vaccines. (2021) 21:82&#x2013;9. 10.1080/14760584.2022.2002690</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2022.2002690</ArticleId><ArticleId IdType="pmc">PMC8607534</ArticleId><ArticleId IdType="pubmed">34738500</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol. (2020) 45:100618. 10.1016/j.cpcardiol.2020.100618</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100618</ArticleId><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. (2020) 143:3104&#x2013;20. 10.1093/brain/awaa240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen J, Reimer KC, Nagai JS, Varghese FS, Overheul GJ, de Beer M, et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. (2021). 29, 217&#x2013;31. 10.1016/j.stem.2021.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8709832</ArticleId><ArticleId IdType="pubmed">35032430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. (2020) 77:683&#x2013;90. 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Research (Washington DC). (2020) 2020:2402961. 10.34133/2020/2402961</Citation><ArticleIdList><ArticleId IdType="doi">10.34133/2020/2402961</ArticleId><ArticleId IdType="pmc">PMC7187729</ArticleId><ArticleId IdType="pubmed">32377638</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Go&#xdf;ling A, Adam G, Aepfelbacher M, Behrendt C-A, Cavus E, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg city health study COVID programme. Eur Heart J. (2022) 43:1124&#x2013;37. 10.1093/eurheartj/ehab914</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanacli R, Doeblin P, G&#xf6;tze C, Zieschang V, Faragli A, Stehning C, et al. COVID-19 vs. classical myocarditis associated myocardial injury evaluated by cardiac magnetic resonance and endomyocardial biopsy. Front Cardiovasc Med. (2021) 8:1825. 10.3389/fcvm.2021.737257</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.737257</ArticleId><ArticleId IdType="pmc">PMC8739473</ArticleId><ArticleId IdType="pubmed">35004872</ArticleId></ArticleIdList></Reference><Reference><Citation>Carubbi F, Alunno A, Leone S, Di Gregorio N, Mancini B, Viscido A, et al. Pericarditis after SARS-CoV-2 infection: another pebble in the mosaic of long COVID? Viruses. (2021) 13:1997. 10.3390/v13101997</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101997</ArticleId><ArticleId IdType="pmc">PMC8540566</ArticleId><ArticleId IdType="pubmed">34696427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. (2014) 16:2. 10.1186/1532-429X-16-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1532-429X-16-2</ArticleId><ArticleId IdType="pmc">PMC3927683</ArticleId><ArticleId IdType="pubmed">24387626</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. (2001) 218:215&#x2013;23. 10.1148/radiology.218.1.r01ja50215</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.218.1.r01ja50215</ArticleId><ArticleId IdType="pubmed">11152805</ArticleId></ArticleIdList></Reference><Reference><Citation>Masci PG, Francone M, Desmet W, Ganame J, Todiere G, Donato R, et al. Right ventricular ischemic injury in patients with acute st-segment elevation myocardial infarction. Circulation. (2010) 122:1405&#x2013;12. 10.1161/CIRCULATIONAHA.110.940254</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.940254</ArticleId><ArticleId IdType="pubmed">20855663</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehwald WG, Fieno DS, Chen E-L, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation. (2002) 105:224&#x2013;9. 10.1161/hc0202.102016</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc0202.102016</ArticleId><ArticleId IdType="pubmed">11790705</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkbey EB, Nacif MS, Guo M, McClelland RL, Teixeira PBRP, Bild DE, et al. Prevalence and correlates of myocardial scar in a US cohort. JAMA. (2015) 314:1945&#x2013;54. 10.1001/jama.2015.14849</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.14849</ArticleId><ArticleId IdType="pmc">PMC4774246</ArticleId><ArticleId IdType="pubmed">26547466</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>